India seems set to reverse a ten year-old policy governing foreign direct investment (FDI) in pharmaceuticals. If Prime Minister Manmohan Singh gives his nod to the recommendations of an inter-ministerial group then automatic approval for FDI in Indian drug companies will be capped at 49 per cent. Beyond this limit, a foreign investor will have … Continue reading FDI in pharma : India’s quick fix
Apothecurry 